Avecho Biotechnology Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33	33	8	11	28	28
Market Cap Growth	108.63%	317.27%	-28.57%	-59.76%	0.10%	-40.60%
Enterprise Value	28	27	3	8	24	23
Last Close Price	0.01	0.01	0.00	0.00	0.01	0.01
PS Ratio	26.71	26.71	7.00	23.42	24.41	34.71
PB Ratio	21.20	21.20	2.42	1.74	11.37	6.07
P/TBV Ratio	21.20	21.20	2.42	1.74	11.49	6.21
P/FCF Ratio	-	29.97	-	-	-	-
P/OCF Ratio	29.97	29.97	-	-	-	-
EV/Sales Ratio	22.95	21.96	2.85	17.81	21.69	28.84
EV/FCF Ratio	-	24.64	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.33	0.03	0.10	0.02
Debt / FCF Ratio	0.01	0.01	-	-	-	-
Net Debt / Equity Ratio	-2.98	-2.98	-0.40	-0.84	-0.50	-0.70
Net Debt / EBITDA Ratio	1.22	1.22	0.44	1.64	0.58	1.07
Net Debt / FCF Ratio	-4.21	-4.21	0.33	1.68	0.71	0.96
Asset Turnover	0.21	0.21	0.18	0.09	0.26	0.19
Inventory Turnover	4.80	4.80	3.93	2.07	1.12	1.93
Quick Ratio	9.68	9.68	2.70	7.83	2.97	6.31
Current Ratio	9.95	9.95	2.81	8.31	3.83	6.91
Return on Equity (ROE)	-182.91%	-182.91%	-64.72%	-78.08%	-67.30%	-95.01%
Return on Assets (ROA)	-40.85%	-40.85%	-31.11%	-40.10%	-33.99%	-49.50%
Return on Capital Employed (ROCE)	-61.80%	-61.80%	-93.30%	-52.80%	-89.80%	-74.90%
Earnings Yield	-13.36%	-13.36%	-39.40%	-30.98%	-8.50%	-12.40%
FCF Yield	-	3.34%	-50.09%	-28.67%	-6.23%	-11.99%
Buyback Yield / Dilution	-1.05%	-3.08%	-39.73%	-23.41%	-1.97%	-13.27%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.